Quanterix Reports 20% Q1 Revenue Growth, Narrows Loss, Reaffirms 2026 Cash Flow Breakeven Target

summarizeSummary

Quanterix reported strong Q1 2026 revenue growth of 20% and a narrowed adjusted EBITDA loss, reaffirming its full-year guidance and commitment to achieving cash flow breakeven in the second half of 2026, signaling operational improvement.

check_boxKey Events

• Strong Q1 Revenue Growth

  Reported $36.4 million in revenue for the first quarter of 2026, marking a 20% increase compared to the prior year.

• Narrowed Adjusted EBITDA Loss

  Adjusted EBITDA loss improved to $9.8 million, down from a loss of $11.3 million in the first quarter of 2025.

• Reaffirmed 2026 Guidance

  Maintained full-year revenue guidance of $169 million to $174 million and reiterated its commitment to achieving cash flow breakeven in the second half of 2026.

• Solid Cash Position

  Ended the first quarter with $102.6 million in cash, cash equivalents, marketable securities, and restricted cash.

auto_awesomeAnalysis

This 8-K reports Quanterix's first-quarter 2026 financial results, demonstrating significant operational improvements and strategic progress. The 20% year-over-year revenue growth and narrowed adjusted EBITDA loss are positive indicators, especially following a challenging 2025 characterized by increased net losses and goodwill impairment. The reaffirmation of full-year guidance, including the critical target of achieving cash flow breakeven in the second half of 2026, provides a strong signal of stabilization and potential turnaround for the company. Investors should monitor progress towards the cash flow breakeven target and the execution of new diagnostic collaborations.